本地实体 vs 本地代表：两条落地路径的代价比较

I. Key takeaways

An overseas manufacturer entering Cambodia has only two routes, and their cost structures are entirely different:

GRZAN note: the two routes differ on 3 core dimensions — entity qualifications (2 licences), staffing qualifications (1 registered pharmacist) and control; the local entity may be 100% foreign-owned.

II. Legal basis

III. Expert commentary

1. Article 4 (new) of the 2007 Amendment Law is the legal key to foreign investment. Article 4 of the original 1996 law restricted operating eligibility to pharmacists of Cambodian nationality; the Amendment Law opens eligibility to foreign nationals and to women, while keeping the technical requirements with Cambodian pharmacists. This “open the entity, hold the technique” structure is a typical Cambodian design for attracting foreign investment without abandoning technical control.

1. “May be 100% foreign-owned” is an underrated advantage. Within ASEAN, some markets cap foreign shareholding in pharmaceutical distribution. Cambodia allows a wholly foreign-owned local entity; for manufacturers that want full control of registration and channels, Route A is more feasible and attractive than a surface reading suggests.

1. The real variable in route selection is not cost but the freedom to change channels. If a single importer serves as both applicant and distributor, changing the distribution channel later affects ownership of the registration certificate. With an independent third-party authorised representative, or an own entity, changing channels leaves the certificate untouched. Make this the first decision criterion, ahead of the initial outlay.

IV. Practical recommendations

1. Choose the route by product line count and market commitment horizon. For a single product line, choose Route B; with three or more product lines or a commitment of three years or more, Route A has a lower diluted cost.
2. If Route B is chosen, separate the representative function from the distribution function. Use an independent third-party authorised representative so the importer does not hold both the certificate and the channel.
3. For Route A, solve pharmacist recruitment up front. Pharmacy Council of Cambodia membership is a limited resource and recruitment can take longer than company incorporation, so start both in parallel.

V. Verification checklist

• □ Route selected based on product line count and market commitment horizon
• □ Route A: Certificate of Incorporation and pharmaceutical enterprise licence processes started
• □ Route A: Pharmacy Council of Cambodia member recruitment started
• □ Route B: representative’s Certificate of Incorporation and Import-Export Pharmaceutical Company Licence verified
• □ Route B: agreement that the representative function is separate from the distribution function
• □ Impact of future distribution channel changes on certificate ownership assessed

Regulatory information verified as of 29 October 2026.

In Southeast Asia, GRZAN’s core capabilities focus on three areas. First, tracking the legislative progress of dedicated medical device laws across member states: Singapore, Malaysia, Thailand, Indonesia, the Philippines and Vietnam have each established written device regulatory frameworks, while Cambodia still has no dedicated Medical Device Law; the current rules are pieced together from three layers — the registration-number legal basis provided by the 1996 Law on the Management of Pharmaceuticals and its 2007 Amendment Law, the classification and procedures provided by Prakas No. 1258 of 2012, and the technical framework provided by the ASEAN Medical Device Directive (AMDD) — so compliance certainty is markedly lower than in markets that have completed legislation. Second, local authorised representative services: GRZAN acts as the manufacturer’s statutory representative in Cambodia, handling registration submissions, regulatory communication and post-market reporting obligations, and helping resolve the practical issues of the Cambodian registered pharmacist and the Import-Export Pharmaceutical Company Licence. Third, quality system and testing support: establishing a quality management system conforming to ISO 13485 and organising the technical dossier under the ASEAN Common Submission Dossier Template (CSDT).

Business enquiries: info@grzanglobal.com